Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America

Código QR

Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America

Abstract The prevalence and contribution of BRCA1/2 (BRCA) pathogenic variants (PVs) to the cancer burden in Latin America are not well understood. This study aims to address this disparity. BRCA analyses were performed on prospectively enrolled Latin American Clinical Cancer Genomics Community Rese...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Josef S. Herzog, Yanin Chavarri-Guerra, Danielle Castillo, Julio Abugattas, Cynthia Villarreal-Garza, Sharon Sand, Jessica Clague-Dehart, Rosa M. Alvarez-Gómez, Talia Wegman-Ostrosky, Alejandro Mohar, Pamela Mora, Azucena Del Toro-Valero, Adrian Daneri-Navarro, Yenni Rodriguez, Marcia Cruz-Correa, Patricia Ashton-Prolla, Bárbara Alemar, Rosa Mejia, Lenny Gallardo, Robin Shaw, Kai Yang, Aleck Cervantes, Kevin Tsang, Bita Nehoray, Hugo Barrera Saldana, Susan Neuhausen, Jeffrey N. Weitzel
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/cf08a7f700d74cf8b958e3c34a9237a2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Kara N. Maxwell, et al.
Publicado: (2017)

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Ilirjana Bajrami, et al.
Publicado: (2021)

Telomere length shows no association with BRCA1 and BRCA2 mutation status.
por: Emma Killick, et al.
Publicado: (2014)

BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
por: Lara,Karlena, et al.
Publicado: (2012)

In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing
por: Kok-Siong Poon
Publicado: (2021)

Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
por: D. Torres, et al.
Publicado: (2017)

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.
por: Nicolai Juul Birkbak, et al.
Publicado: (2013)

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
por: Dominik Glodzik, et al.
Publicado: (2020)

Clinical consequences of BRCA2 hypomorphism
por: Laia Castells-Roca, et al.
Publicado: (2021)

A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
por: Miyuki Kitahara, et al.
Publicado: (2021)

Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations
por: Neil M. Iyengar, et al.
Publicado: (2021)

Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
por: Hikmat Abdel-Razeq, et al.
Publicado: (2021)

Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
por: Yanying Huo, et al.
Publicado: (2021)

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.
por: Felipe Vaca-Paniagua, et al.
Publicado: (2012)

Next-generation sequencing of BRCA1 and BRCA2 genes in Moroccan prostate cancer patients with positive family history.
por: Fatiha Salmi, et al.
Publicado: (2021)

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
por: Supriya Behl, et al.
Publicado: (2020)

Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
por: Martin J Larsen, et al.
Publicado: (2013)

Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations
por: Jara,Lilian, et al.
Publicado: (2017)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
por: Juliette Coignard, et al.
Publicado: (2021)

Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer.
por: Louise J Barber, et al.
Publicado: (2011)

Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
por: Shoko Takeuchi, et al.
Publicado: (2018)

BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.
por: Gaik Theng Toh, et al.
Publicado: (2008)

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
por: Juliette Coignard, et al.
Publicado: (2021)

Cáncer de mama familiar, BRCA1 positivo
por: FIGUEROA G,LUIS, et al.
Publicado: (2009)

BRCA2 mutations and triple-negative breast cancer.
por: Peter Meyer, et al.
Publicado: (2012)

Mutations in BRCA2 and taxane resistance in prostate cancer
por: Cathleen Nientiedt, et al.
Publicado: (2017)

Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
por: Ana Blanco, et al.
Publicado: (2013)

Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
por: Dirce Maria Carraro, et al.
Publicado: (2013)

The BRCA2-MEILB2-BRME1 complex governs meiotic recombination and impairs the mitotic BRCA2-RAD51 function in cancer cells
por: Jingjing Zhang, et al.
Publicado: (2020)

Absence of BRCA/FMR1 correlations in women with ovarian cancers.
por: Norbert Gleicher, et al.
Publicado: (2014)

Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer.
por: Franziska Pern, et al.
Publicado: (2012)

BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?
por: Andrea Weghofer, et al.
Publicado: (2012)

Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.
por: Aida Bianco, et al.
Publicado: (2013)

Analysis of 5382insC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer
por: JARA,LILIAN, et al.
Publicado: (2002)

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
por: Mia M Gaudet, et al.
Publicado: (2010)

Pathogenic <i>BRCA</i> Variants as Biomarkers for Risk in Prostate Cancer
por: Ciara S. McNevin, et al.
Publicado: (2021)

High-throughput functional evaluation of BRCA2 variants of unknown significance
por: Masachika Ikegami, et al.
Publicado: (2020)

Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1
por: Åsa Ehlén, et al.
Publicado: (2020)

Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
por: Xia Ding, et al.
Publicado: (2016)

BRCA1 degradation in response to mitochondrial damage in breast cancer cells
por: Kana Miyahara, et al.
Publicado: (2021)